Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease

Objective: The very low-density lipoprotein receptor (VLDLR) plays an important role in the development of hepatic steatosis. In this study, we investigated the role of Peroxisome Proliferator-Activated Receptor (PPAR)β/δ and fibroblast growth factor 21 (FGF21) in hepatic VLDLR regulation. Methods:...

Full description

Bibliographic Details
Main Authors: Mohammad Zarei, Barroso, Emma, Palomer, Xavier, Dai, Jianli, Rada, Patricia, Quesada-López, Tania, Escolà-Gil, Joan Carles, Cedó, Lidia, Mohammad Reza Zali, Molaei, Mahsa, Dabiri, Reza, Vázquez, Santiago, Pujol, Eugènia, Valverde, Ángela M., Villarroya, Francesc, Liu, Yong, Wahli, Walter, Vázquez-Carrera, Manuel
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Journal Article
Language:English
Published: 2018
Subjects:
Online Access:https://hdl.handle.net/10356/85541
http://hdl.handle.net/10220/45208
_version_ 1826121119024807936
author Mohammad Zarei
Barroso, Emma
Palomer, Xavier
Dai, Jianli
Rada, Patricia
Quesada-López, Tania
Escolà-Gil, Joan Carles
Cedó, Lidia
Mohammad Reza Zali
Molaei, Mahsa
Dabiri, Reza
Vázquez, Santiago
Pujol, Eugènia
Valverde, Ángela M.
Villarroya, Francesc
Liu, Yong
Wahli, Walter
Vázquez-Carrera, Manuel
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Mohammad Zarei
Barroso, Emma
Palomer, Xavier
Dai, Jianli
Rada, Patricia
Quesada-López, Tania
Escolà-Gil, Joan Carles
Cedó, Lidia
Mohammad Reza Zali
Molaei, Mahsa
Dabiri, Reza
Vázquez, Santiago
Pujol, Eugènia
Valverde, Ángela M.
Villarroya, Francesc
Liu, Yong
Wahli, Walter
Vázquez-Carrera, Manuel
author_sort Mohammad Zarei
collection NTU
description Objective: The very low-density lipoprotein receptor (VLDLR) plays an important role in the development of hepatic steatosis. In this study, we investigated the role of Peroxisome Proliferator-Activated Receptor (PPAR)β/δ and fibroblast growth factor 21 (FGF21) in hepatic VLDLR regulation. Methods: Studies were conducted in wild-type and Pparβ/δ-null mice, primary mouse hepatocytes, human Huh-7 hepatocytes, and liver biopsies from control subjects and patients with moderate and severe hepatic steatosis. Results: Increased VLDLR levels were observed in liver of Pparβ/δ-null mice and in Pparβ/δ-knocked down mouse primary hepatocytes through mechanisms involving the heme-regulated eukaryotic translation initiation factor 2α (eIF2α) kinase (HRI), activating transcription factor (ATF) 4 and the oxidative stress-induced nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathways. Moreover, by using a neutralizing antibody against FGF21, Fgf21-null mice and by treating mice with recombinant FGF21, we show that FGF21 may protect against hepatic steatosis by attenuating endoplasmic reticulum (ER) stress-induced VLDLR upregulation. Finally, in liver biopsies from patients with moderate and severe hepatic steatosis, we observed an increase in VLDLR levels that was accompanied by a reduction in PPARβ/δ mRNA abundance and DNA-binding activity compared with control subjects. Conclusions: Overall, these findings provide new mechanisms by which PPARβ/δ and FGF21 regulate VLDLR levels and influence hepatic steatosis development.
first_indexed 2024-10-01T05:27:31Z
format Journal Article
id ntu-10356/85541
institution Nanyang Technological University
language English
last_indexed 2024-10-01T05:27:31Z
publishDate 2018
record_format dspace
spelling ntu-10356/855412020-11-01T05:20:52Z Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease Mohammad Zarei Barroso, Emma Palomer, Xavier Dai, Jianli Rada, Patricia Quesada-López, Tania Escolà-Gil, Joan Carles Cedó, Lidia Mohammad Reza Zali Molaei, Mahsa Dabiri, Reza Vázquez, Santiago Pujol, Eugènia Valverde, Ángela M. Villarroya, Francesc Liu, Yong Wahli, Walter Vázquez-Carrera, Manuel Lee Kong Chian School of Medicine (LKCMedicine) VLDLR PPAR Objective: The very low-density lipoprotein receptor (VLDLR) plays an important role in the development of hepatic steatosis. In this study, we investigated the role of Peroxisome Proliferator-Activated Receptor (PPAR)β/δ and fibroblast growth factor 21 (FGF21) in hepatic VLDLR regulation. Methods: Studies were conducted in wild-type and Pparβ/δ-null mice, primary mouse hepatocytes, human Huh-7 hepatocytes, and liver biopsies from control subjects and patients with moderate and severe hepatic steatosis. Results: Increased VLDLR levels were observed in liver of Pparβ/δ-null mice and in Pparβ/δ-knocked down mouse primary hepatocytes through mechanisms involving the heme-regulated eukaryotic translation initiation factor 2α (eIF2α) kinase (HRI), activating transcription factor (ATF) 4 and the oxidative stress-induced nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathways. Moreover, by using a neutralizing antibody against FGF21, Fgf21-null mice and by treating mice with recombinant FGF21, we show that FGF21 may protect against hepatic steatosis by attenuating endoplasmic reticulum (ER) stress-induced VLDLR upregulation. Finally, in liver biopsies from patients with moderate and severe hepatic steatosis, we observed an increase in VLDLR levels that was accompanied by a reduction in PPARβ/δ mRNA abundance and DNA-binding activity compared with control subjects. Conclusions: Overall, these findings provide new mechanisms by which PPARβ/δ and FGF21 regulate VLDLR levels and influence hepatic steatosis development. Published version 2018-07-24T08:13:54Z 2019-12-06T16:05:39Z 2018-07-24T08:13:54Z 2019-12-06T16:05:39Z 2017 Journal Article Mohammad Zarei, Barroso, E., Palomer, X., Dai, J., Rada, P., Quesada-López, T., et al. (2018). Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease. Molecular Metabolism, 8, 117-131. 2212-8778 https://hdl.handle.net/10356/85541 http://hdl.handle.net/10220/45208 10.1016/j.molmet.2017.12.008 en Molecular Metabolism © 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 15 p. application/pdf
spellingShingle VLDLR
PPAR
Mohammad Zarei
Barroso, Emma
Palomer, Xavier
Dai, Jianli
Rada, Patricia
Quesada-López, Tania
Escolà-Gil, Joan Carles
Cedó, Lidia
Mohammad Reza Zali
Molaei, Mahsa
Dabiri, Reza
Vázquez, Santiago
Pujol, Eugènia
Valverde, Ángela M.
Villarroya, Francesc
Liu, Yong
Wahli, Walter
Vázquez-Carrera, Manuel
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
title Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
title_full Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
title_fullStr Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
title_full_unstemmed Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
title_short Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
title_sort hepatic regulation of vldl receptor by pparβ δ and fgf21 modulates non alcoholic fatty liver disease
topic VLDLR
PPAR
url https://hdl.handle.net/10356/85541
http://hdl.handle.net/10220/45208
work_keys_str_mv AT mohammadzarei hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT barrosoemma hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT palomerxavier hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT daijianli hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT radapatricia hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT quesadalopeztania hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT escolagiljoancarles hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT cedolidia hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT mohammadrezazali hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT molaeimahsa hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT dabirireza hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT vazquezsantiago hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT pujoleugenia hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT valverdeangelam hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT villarroyafrancesc hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT liuyong hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT wahliwalter hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease
AT vazquezcarreramanuel hepaticregulationofvldlreceptorbypparbdandfgf21modulatesnonalcoholicfattyliverdisease